Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomedical and Biopharmaceutical Research is Scopus-indexed (Q3, CiteScore 0.6). Published by ALIES.
Checked against the index lists dated .
ISSN 2182-2360Verify ISSN ↗2182-2379Verify ISSN ↗
Publisher: ALIES
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacy | 37 / 52 | 29th | Q3 |
| Pharmacology (medical) | 241 / 278 | 13th | Q4 |
| Pharmacology, Toxicology and Pharmaceutics (all) | 71 / 79 | 10th | Q4 |
| Food Science | 384 / 420 | 8th | Q4 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q3, CiteScore 0.6.
Biomedical and Biopharmaceutical Research is Q3 in Pharmacy (rank 37 of 52), Q4 in Pharmacology (medical) (rank 241 of 278) and Q4 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 71 of 79), by CiteScore 2025. It is ranked in 4 subject areas in all.
Biomedical and Biopharmaceutical Research is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.6, quartile Q3, 29th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.144, quartile Q4, with an H-index of 6.
Biomedical and Biopharmaceutical Research is published by ALIES. Its print ISSN is 2182-2360 and its online ISSN is 2182-2379.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biomedical and Biopharmaceutical Research has an h-index of 12 and a 2-year mean of 0.18 citations per paper (OpenAlex). Its Scopus CiteScore is 0.6, quartile Q3. On 2-year citations it ranks #39 of 50 Scopus journals in Pharmacy.
Biomedical and Biopharmaceutical Research published 25 papers in 2025; its busiest recent year was 2022 with 31. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2022–2026), authors are most often from Portugal (49%), France (21.9%) and Brazil (11.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.